Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0000950170-24-023330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-02-29 | 2024-02-27 | FDMT | Bizily Scott | CLO | M - OptEx | $20.24 | +1,909 | 3,646 | +110% | +$38.6K |
| DT | 2024-02-29 | 2024-02-27 | FDMT | Bizily Scott | CLO | S - Sale+OE | $30.00 | -1,909 | 1,737 | -52% | -$57.3K |
| DT | 2024-02-29 | 2024-02-27 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -1,909 | 48.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | M | A | 1,909 | $20.24 | 3,646 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-27 | S | D | 1,909 | $30.00 | 1,737 | D | — | — | |
| 3 | Derivative | Stock Option (Right To Buy) | 2024-02-27 | M | D | 1,909 | $0.00 | 48,091 | D | $20.24 · — to 2032-06-17 | 1,909 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 10, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |